Enviaments recents

The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells

Garcia Vicién, Gemma; Ruiz, Nuria; Ruffinelli, Jose Carlos; Mils, Kristel; Bañuls, María; Micke, Patrick; Mezheyeuski, Artur (Data de publicació: 2025-01-10)

Desmoplasia; Hepatic metastases; Histologic growth pattern

Gestational breast cancer: distinctive molecular and clinico-epidemiological features

Minguez, Pablo; Rojo, Federico; Martin, Miguel; Alba Conejo, Emilio; Servitja Tormo, Sonia; Haba Rodríguez, Juan Rafael de la; Prat, Aleix (Data de publicació: 2025-02-26)

Breast cancer; Gene expression; Gestational breast cancer

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

KAMPOSIORAS, KONSTANTNOS; Haanen, John; Hardy, Claire; Murali, Krithika; Lim, Kok Haw Jonathan; Elez, Elena (Data de publicació: 2024-12-16)

Burnout; Oncology professionals; Psychosocial risk

Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours

Groelly, Florian; Porru, Manuela; Zimmer, Jutta; Benainous, Hugo; De Visser, Yanti; Kosova, Anastasiya; Serra Elizalde, Violeta (Data de publicació: 2022-07-25)

BRCA2; DNA damage responses; Pyridostatin

Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study

Ajani, Jaffer A; FARID, EL HAJBI; Cunningham, David; Thuss-Patience, Peter; Scagliotti, Giorgio; Alsina, Maria (Data de publicació: 2024-01-31)

Esophageal squamous cell carcinoma; Tislelizumab

Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer

Yong, Wei Peng; Shiu, Kai-Keen; Vittrup, Benny; Elez Fernandez, Mª Elena; Yoshino, Takayuki; André, Thierry; Kim, Tae Won (Data de publicació: 2023-04-26)

Asia; Colorectal cancer; Pembrolizumab

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers

Voulgarelis, Dimitrios; Forment, Josep; Polychronopoulos, Dimitris; Cohen-Setton, Jake; Bender, Andreas; Herencia Ropero, Andrea (Data de publicació: 2025-02-03)

Tumour growth; Xenograft; PARP inhibition resistance

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity

Marin, Ines; Boix Sanchez, Olga; Garcia Garijo, Andrea; Sirois, Isabelle; Caballe, Adria; Zarzuela, Eduardo; Garralda Cabanas, Elena; Gros Vidal, Alena; Abad, Maria (Data de publicació: 2023-03-14)

Senescencia celular; Inmunidad antitumoral

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies

Altena-Kornalijnslijper, Renske; Bajalica Lagercrantz, Svetlana; Papakonstantinou, Andri (Data de publicació: 2022-10-26)

Breast cancer; Cardiotoxicity; Pharmacogenomics

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer

Ayodele, Olubukola; Wang, Ben Xuhao; Hernando-Calvo, Alberto; Bruce, Jeff; Abbas-Aghababazadeh, Farnoosh; Vila-Casadesús, Maria; Vivancos, Ana; Han, Ming (Data de publicació: 2024-10-01)

Biomarkers; Colorectal cancer; Immunotherapy

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

Capitán-Leo, Daniel; Casacuberta-Serra, Sílvia; González-Larreategui, Íñigo; Soucek, Laura (Data de publicació: 2025-02-12)

MYC; Oncogenes; Cancer

A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1

Arranz Arija, José Ángel; Colomba, Emeline; Gravis, Gwenaelle; Agarwal, Neeraj; Castellano, Daniel; Macarena, Gonzalez (Data de publicació: 2024-06-05)

Abemaciclib; Pretreated; Metastatic prostate cancer

Avapritinib in unresectable or metastatic PDGFRA D842V - mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

Jones, Robin L.; Serrano Garcia, César; von Mehren, Margaret; Heinrich, Michael C.; Kang, Yoon-Koo; George, Suzanne (Data de publicació: 2021-07-05)

Avapritinib; Tumors de l'estroma gastrointestinal; PDGFRA

Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer

Panisello, Carla; Tirtakasuma, Ricky; Díaz-Gómez, Judit; Grases Mendoza, Daniela; Pasamar Garijo, Helena; Vivancos Prellezo, Ana; Gos, Alena; Palomero, Jara; Lozano Rabella, Maria (Data de publicació: 2023-02-01)

Neoplasias genitales; Inmunoterapia; Linfocitos T

MIA40 circumvents the folding constraints imposed by TRIAP1 function

Pujols Pujol, Jordi; Fornt-Suñé, Marc; Gil-Garcia, Marcos; Bartolomé-Nafría, Andrea; Cerofolini, Linda; Canals, Francesc (Data de publicació: 2025-03-21)

Folding intermediates; Molten globule; Oxidative folding

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects

Gion, María; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Cortés Castan, Javier; Sampayo-Cordero, Miguel; Malfettone, Andrea (Data de publicació: 2022-06-09)

Breast cancer subtypes; Neoadjuvant therapy; Surrogate markers

Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study

Villabona, Lisa; Lawrence, Ben; Arance, Ana; Butler, Marcus; Beylot-Barry, Marie; MORTIER, Laurent; Capdevila Castillon, Jaume (Data de publicació: 2024-11-07)

Merkel Cell Carcinoma; Results

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples

Vivancos Prellezo, Ana; Benavides, Manuel; Elez Fernandez, Mª Elena; Gómez-España, Maria Auxiliadora; Toledano, Marta; Aranda Aguilar, Enrique (Data de publicació: 2019-08-21)

Biopsy; KRAS mutation; Colorectal cancer

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey

Hernando, Jorge; Kolarova, Teodora; Verslype, Chris; Kaltsas, Gregory; Houchard, Aude; Gueguen, Delphine; de Herder, Wouter (Data de publicació: 2023-07-03)

Injection experience; Neuroendocrine tumors; Somatostatin analog

Cdk9 and H2Bub1 signal to Clr6-CII/Rpd3S to suppress aberrant antisense transcription

Sanso Martinez, Miriam; Parua, Pabitra K.; Pinto, Daniel; Svensson, J. Peter; Pagé, Viviane; Bitton, Danny A. (Data de publicació: 2021-11-04)

Regulació gènica

Articles científics - VHIO: Enviaments recents

The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells ﻿

Gestational breast cancer: distinctive molecular and clinico-epidemiological features ﻿

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology ﻿

Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1/2-deficient tumours ﻿

Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study ﻿

Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer ﻿

Understanding tumour growth variability in breast cancer xenograft models identifies PARP inhibition resistance biomarkers ﻿

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity ﻿

Pharmacogenomics for Prediction of Cardiovascular Toxicity: Landscape of Emerging Data in Breast Cancer Therapies ﻿

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer ﻿

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer ﻿

A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1 ﻿

Avapritinib in unresectable or metastatic PDGFRA D842V - mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial ﻿

Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer ﻿

MIA40 circumvents the folding constraints imposed by TRIAP1 function ﻿

Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects ﻿

Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study ﻿

Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples ﻿

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey ﻿

Cdk9 and H2Bub1 signal to Clr6-CII/Rpd3S to suppress aberrant antisense transcription ﻿